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Abstract
Background: Gestational diabetes mellitus (GDM) is increasing, along with obesity and type 2 diabetes (T2DM), with
Aboriginal and Torres Strait Islander (Aboriginala) women in Australia particularly affected. GDM causes serious
complications in pregnancy, birth, and the longer term, for women and their infants. Women with GDM have an
eightfold risk of developing T2DM after pregnancy, compared to women without GDM. Indigenous women have an
even higher risk, at a younger age, and progress more quickly from GDM to T2DM, compared to non-Indigenous
women. If left undetected and untreated, T2DM increases risks in subsequent pregnancies, and can lead to heart
disease, stroke, kidney failure, limb amputations and blindness for the woman in the longer term. A GDM diagnosis
offers a ‘window of opportunity’ to provide acceptable and effective prevention, treatment, and postpartum care. Low
rates of postpartum T2DM screening are reported among non-Aboriginal women in Australia and Indigenous
women in other countries, however, data for Aboriginal women in Australia are scarce. A healthy diet, exercise and
breastfeeding can delay the onset of T2DM, and together with T2DM screening are recommended elements of
postpartum care for women with GDM. This paper describes methods for a study evaluating postpartum care
among Aboriginal and non-Aboriginal women with GDM.
Methods/Design: This retrospective cohort includes all women who gave birth at Cairns Hospital in far north
Queensland, Australia, from 2004 to 2010, coded as having GDM in the Cairns Hospital Clinical Coding system. Data is
being linked with the Midwives Perinatal Data Collection, and the three local laboratories. Hospital medical records are
being reviewed to validate accuracy of GDM case ascertainment, and gather information on breastfeeding and
provision of dietary advice. Survival analysis is being used to estimate time to screening, and rates of progression from
GDM to T2DM. Logistic regression is being used to compare postpartum care between Aboriginal and non-Aboriginal
women, and assess factors that may be associated with provision of postpartum care.
Discussion: There are challenges to collecting postpartum data for women with GDM, however, this research is
urgently needed to ensure adequate postpartum care is provided for women with GDM.
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Background
Gestational diabetes mellitus (GDM) is increasing along
with obesity (Hunt and Schuller 2007) and type 2 diabetes
mellitus (T2DM) (Sicree et al. 2009; Australian Institute of
Health and Welfare 2010b), with Indigenousa populations
particularly affected (Naqshbandi et al. 2008). GDM causes
serious complications in pregnancy, birth (HAPO Study
Cooperative Research Group 2008; Coustan et al. 2010)
and the longer term (Dyck et al. 2010), for both women
and their infants. Compared to non-Indigenous women,
Indigenous women have a higher risk of GDM (Steinhart
et al. 1997; Dyck 2005; Young et al. 2002), at a younger age
(Yue et al. 1996; Benjamin et al. 1993), and there is a much
higher rate of both diagnosed and undiagnosed T2DM in
pregnancy (Australian Institute of Health and Welfare
2010b). Women diagnosed with GDM have a very high
risk of developing T2DM postpartum, compared to
women who do not have GDM (Kim 2002; Bentley-Lewis
et al. 2008; Chodick et al. 2010; Bellamy et al. 2009; Heikes
et al. 2008), and Indigenous women experience the highest
risk (Yue et al. 1996; Kim 2002). The emergence of diabetic
disorders among young child-bearing women represents
an ominous ‘tipping point’ (Canadian Diabetes Association
2011) in the diabetes epidemic (Yue et al. 1996), as expo-
sure to diabetes in-utero also significantly compounds the
health risks for the next generation (Dyck et al. 2010;
Osgood et al. 2011), and GDM becomes an additional
driver for T2DM (Bhattarai 2009; Osgood et al. 2011).
T2DM is a serious metabolic disorder, characterised by
hyperglycaemia and, if left undetected and untreated, in-
creases the risk of serious complications in subsequent
pregnancies, including congenital abnormalities (Bower
et al. 1992; Farrell et al. 2002), and can lead to heart dis-
ease, stroke, kidney failure, limb amputations and blindness
(Australian Institute of Health and Welfare 2010a). T2DM
is a major cause of death and disability among Aboriginal
people (Australian Bureau of Statistics 2008) and directly
contributes to health disparities in Australia (Australian
Bureau of Statistics 2010).
GDM includes pre-existing diabetes that has not been
diagnosed before pregnancy, or temporarily glucose in-
tolerance expedited by growth hormones in pregnancy
(American Diabetes Association 2009). The increased in-
sulin demands of pregnancy can ‘unmask’ (Lee et al. 2007)
abnormalities in beta-cell function (Brown and Trost
2003; Moran et al. 2010), forewarning of the risk of pro-
gression to T2DM (Bilhartz et al. 2011). Most importantly,
it offers a unique ‘window of opportunity’ for public health
strategies because young women with no other identified
conditions usually have frequent scheduled contacts with
health-care providers for pregnancy care, often for the first
time since early childhood. Pregnant women are also often
highly motivated to adapt their lifestyles to improve the
health of their infant (Kalra et al. 2011), with any effective
support potentially benefitting the whole family (McBride
et al. 2003; Orleans et al. 2000). The postpartum period
also offers unique opportunities for women to reduce their
risk (Schwarz et al. 2010; Liu et al. 2010) and the long-
term risk for their infant (Owen et al. 2006; Pettitt et al.
1997), through breastfeeding.
Evidence about the risks of GDM (Coustan et al. 2010)
has led to changes to international (International Associ-
ation of Diabetes and Pregnancy Study Groups 2010) and
national screening guidelines (Teh et al. 2011; Nankervis
et al. 2013). The major changes include: offering screening
in early pregnancy for women at high risk of T2DM,
in addition to 24–28 weeks’ as is currently recommended;
separating ‘probable’ undiagnosed T2DM from GDM;
and changing the diagnostic thresholds for GDM. These
changes are likely to significantly increase the prevalence
of GDM in Australia (Round et al. 2010; Moses et al. 2011;
Lindsay 2011; Morikawa et al. 2010; Leiberman et al. 2011;
Flack et al. 2010; O’Sullivan et al. 2011), and have particular
implications for Aboriginala women, who are categorised as
having a high risk of T2DM (Chamberlain et al. 2011).
While there are potential benefits, there are key criteria for
introducing population-based screening, which specify that
the benefits must outweigh the risks and inconvenience
(Wilson and Jungner 1968), and that effective prevention,
treatment and follow-up (postpartum) are provided
(Australian Health Ministers’Advisory Council 2008).
Despite the clear evidence of an increased risk of deve-
loping T2DM (Steinhart et al. 1997; Dyck et al. 2010;
Young et al. 2002; McGrath et al. 2007), there are few stu-
dies investigating rates of postpartum T2DM screening for
Aboriginal women with GDM (Chamberlain et al. 2013).
Low rates of postpartum screening for T2DM have been
reported for non-Indigenous women in Australia (Russell
2006; Morrison et al. 2009; Kim 2007; Sterne et al. 2011)
and internationally (Pierce et al. 2011; Tovar et al. 2011a;
Keely et al. 2010), as well as Indigenous women in Canada
(Shah et al. 2011; Mohamed and Dooley 1998), New
Zealand (McGrath et al. 2007) and the United States
(Steinhart et al. 1997). A review of postpartum diabetes
screening reported rates ranging from 34% to 73%, with
marked variations by race/ethnicity (Tovar et al. 2011b).
One study reported low rates of postpartum screening
for Aboriginal women in far north Queensland, however
the region is confined to remote areas only and num-
bers were too small to assess trends (Davis et al. 2013).
These low rates of postpartum T2DM screening are in
stark contrast to high rates of postpartum screening
for cervical cancer (Sterne et al. 2011), with one study
reporting only 37% of eligible women underwent a
postpartum Oral Glucose Tolerance Test (OGTT),
while 94% underwent a postpartum papanicolaou test
(Smirnakis 2005), which is also perceived as an unplea-
sant test for many women.
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Some of the factors reported as barriers to postpartum
screening include; lack of awareness of the need to attend
screening, the inconvenience of the OGTT (which re-
quires fasting, consuming a glucose drink, and a number
of blood tests over several hours), and the need to attend
with small children (Sterne et al. 2011; Bell et al. 2011;
Clark and Keely 2012). However, there are likely to be
additional barriers for women living in rural and remote
areas (Eades et al. 2010). Rural and remote communities
face challenges accessing health services due to the rugged
and sometimes inaccessible terrain, and they may be re-
quired to travel long distances to access specialist services,
including an OGTT. However, local services are not likely
to incur fees, and individuals are more likely to be person-
ally known to service providers in small communities.
Most Aboriginal people now reside in urban areas, where
there is comparatively limited research, particularly ‘inter-
vention research’ (Eades et al. 2010), and different barriers
which are not well understood (Eades et al. 2010). There
may be limited publicly funded health services in regional
urban areas, and private services may incur substantial
fees. While there may be administrative arrangements to
cover costs for health care card holders and/or Aboriginal
women, these arrangements may not be well understood
by women or healthcare providers in urban areas. While
research suggests relatively simple strategies can increase
postpartum diabetes screening (Carson et al. 2013), such
as: structured systems (Mohamed and Dooley 1998), pro-
active postpartum care plans (Gabbe et al. 2011), antenatal
education (Stasenko et al. 2011), physician reminders (Lega
et al. 2011), patient reminders (Korpi-Hyovalti et al. 2012)
and registers (Dannenbaum et al. 1999), local circum-
stances will need to be considered.
Effective lifestyle and breastfeeding support has been
shown to reduce the risk of T2DM for non-Indigenous
women and their children during (Landon et al. 2009;
Crowther et al. 2005) and after pregnancy (Knowler 2002;
Tuomilehto 2001; Pan 1997; O’Reilly et al. 2011; van der
Pligt et al. 2013). There are no studies reporting effective
diet and exercise support for Aboriginal women with
GDM (Dyck et al. 1998; Gray-Donald et al. 2000; Klomp
et al. 2003; Chamberlain et al. 2013), and studies report a
lower sense of self-efficacy about postpartum weight loss
among women categorised as ‘low socioeconomic status’
(SES). Breastfeeding support has also been shown to be
effective (Karanja et al. 2010) and feasible (Murphy and
Wilson 2008) among Indigenous women in the United
States (US) and Canada, however no studies have been re-
ported in Australia, despite one study suggesting breast-
feeding rates may be lower among Aboriginal women with
GDM than those without (Simmons et al. 2005). This is
not surprising given women with GDM and their infants
are more likely to experience complications which may
inhibit breastfeeding (e.g. caesarean section, neonatal
hypoglycaemia), and evidence these complications are
more likely to have a differential impact on women
categorised as ‘low SES’, as they are more likely to
have lower self-confidence and sense of self-efficacy
about their ability to breastfeed (Demirtas 2012). While
broader strategies addressing environmental determi-
nants have been suggested (O’Dea et al. 2007; Stephenson
1993; Young et al. 2002), no such strategies have yet been
reported (Chamberlain et al. 2013). The paucity of good
quality ‘intervention research’ to prevent T2DM among
Indigenous peoples has similarly been reported (McNamara
et al. 2011), highlighting a gap in diabetes research more
generally.
Adequate support for women diagnosed with GDM is
also important for psychological wellbeing. The diagnosis
of any medical condition can be associated with increased
psychological stress (Sable and Wilkinson 2000), particu-
larly during pregnancy as women are concerned about the
health of their infant (Daniells et al. 2003; Rumbold and
Crowther 2002; Langer and Langer 1994; Cosson 2010).
While recent studies suggest that a GDM diagnosis may
not increase stress among non-Aboriginal women in
Australia (Coustan 2010; Rumbold and Crowther 2002),
it has been reported among ethnic minority groups
(Razee et al. 2010). Furthermore, studies among Indige-
nous women in the US and Canada, report increased stress
(Neufeld 2011) and ‘risk perception’, coupled with low
perceptions of ‘self-efficacy’ associated with a GDM diag-
nosis, despite high levels of knowledge (Jones et al.
2012). Aboriginal women may be more likely to experi-
ence additional stressors. For example, they are more
likely to live in geographically remote areas and may be
required to travel to a major urban city for specialist
care and be thousands of miles from family, and they
are more likely to know people experiencing serious
consequences of T2DM. Effective interventions and post-
partum care are critical to improving confidence and
self-efficacy with regards to lifestyle and breastfeeding,
reducing stress associated with a diagnosis of GDM, and
providing appropriate treatment when needed to miti-
gate the risks to subsequent pregnancies and the long
term risks for women.
Research aims and objectives
This paper describes the methods for a retrospective
cohort study which aims to evaluate postpartum care
for Aboriginal and non-Aboriginal women with GDM
in urban, rural and remote regions in far north Queens-
land from 2004 to 2010. The purpose is to identify bar-
riers and enablers to improve postpartum care for women
with GDM, in all geographic regions. Trend analysis over
time is also essential for evaluating whether improvements
are occurring as changes have been introduced.
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More specifically, the objectives are to:
(1) report the proportion of women diagnosed with
GDM who receive postpartum T2DM screening as
per guidelines (OGTT at 6 weeks, annually and
biannually thereafter) (Queensland Health and Royal
Flying Doctors Service (Queensland Section) 2009);
(2) report the rate of progression from GDM to T2DM;
(3) investigate the recorded rates of other preventive
activities, such as breastfeeding and visits to a
dietician or diabetes educator during pregnancy; and
(4) assess the degree to which confounders impact on
rates of postpartum T2DM screening, progression to
T2DM, breastfeeding, and dietician or diabetes
educator consultations.
Methods
Study design and setting
The study is being conducted in far north Queensland, a
vast region covering almost 300,000 square kilometres on
the north east tip of Australia (See Figure 1), excluding
the Torres Strait Islands. The region has a population of
over 230, 000 people, and approximately 40,000 (17%)
Aboriginal and Torres Strait Islander people (Queensland
Health 2008). About half of the population live in the main
regional (urban) centre of Cairns, which is approximately
1750 kilometres north of the main metropolitan centre
(Brisbane) in Queensland. About 50% of people in this
region live in areas classified as rural and remote, in a
sparsely populated tropical region which has limited
sealed road access and is subject to extreme weather
events, which may make areas even less accessible du-
ring some seasons.
In far north Queensland, there have been a number of
initiatives introduced over the past decade to improve care
for women with GDM. An audit of screening practice
and outcomes during pregnancy (Davis et al. 2009) has
led to introduction of a protocol (Queensland Health
and Royal Flying Doctors Service (Queensland Section)
2009; 2005; 2007) which includes recommendations for
postpartum T2DM screening, promoting breastfeeding,
and providing lifestyle advice. This protocol was intro-
duced in the Torres Strait Islands in 2000 and in the
Cape, an area to the far north of the Australian main-
land, since 2006.
The study cohort is being recruited from Cairns Hospital
(CH), which is the public hospital referral centre in far
north Queensland. The CH catchment area includes Cairns
and hinterland, Cape York and the Torres Strait Islands.
CH provides maternity services for over 80% of women in
far north Queensland, with the remaining women attending
private or other small local public hospitals. It is recom-
mended that all women with diabetes requiring insulin
therapy in pregnancy are referred to CH. During the study
period (1/1/2004–31/12/2010), the diagnostic criteria for
GDM were consistent with the Australian Diabetes in Preg-
nancy Society guidelines (Hoffman et al. 1998), which
required fasting plasma glucose (FPG) > =5.5 mmol/L or
two-hour glucose > =8 mmol/L following a 75 g oral glu-
cose tolerance test (OGTT). However, the standard proced-
ure for GDM screening varied markedly across Australia
during this period (Depczynski et al. 2011), including in far
north Queensland (Davis et al. 2013; 2009). In 2005, pri-
mary care guidelines recommended a random blood
glucose level (RBG) at each pregnancy visit, and if the
level was > =5.0 mmol/L, a fasting blood glucose level
(FBG) was offered (Queensland Health and Royal Flying
Doctors Service (Queensland section) 2005). At 24 weeks,
a RBG was offered again and if > =5.0 mmol/L or the
woman was classified as ‘at risk’ of GDM (Aboriginality
was not a risk factor), a 75 g OGTT was offered. If normal,
the 75 g OGTT was to be offered again at 32 weeks. Gly-
cosylated Haemoglobin (HbA1c) was supposed to be rou-
tinely offered around 28 weeks or at first presentation. In
2007, all Aboriginala women were classified as ‘high risk’
and advised to have a 75 g OGTT at 26–30 weeks gesta-
tion (Queensland Health and Royal Flying Doctors Service
(Queensland section) 2007). In 2009 the guidelines were
revised to recommend a 75 g OGTT at 24 to 28 weeks
gestation (Queensland Health and Royal Flying Doctors
Service (Queensland Section) 2009), as per the Australian
Diabetes in Pregnancy Society guidelines (Hoffman
et al. 1998). GDM screening rates were estimated to be
99.5% on the Torres Strait Islands in 2006 (Falhammar
et al. 2010). Among Aboriginal women in Cape York,
screening rates ranged from 31.4% in 2006 to 65.6%
2008, with a subsequent increase in diagnosis of GDM
from 4.7% in 2006 to 14.7% in 2008 (Rumbold et al.
2011; Davis et al. 2013).
Data sources
The study is using linked electronic data, with key variables
validated by a sample of medical record reviews. Data is be-
ing collected from four main sources: (1) the CH Clinical
Coding (CHCC) system; (2) Midwives Perinatal Data Col-
lection (MPDC); (3) the three laboratories in far north
Queensland, and (4) CH medical records.
(1) Cairns Hospital Clinical Coding (CHCC) system
The study population has been identified from the
CHCC system. This coding is done by
administrative staff, based on what is documented in
the medical records for each inpatient episode. This
data is primarily collected for funding purposes,
though may be used in quality improvement and
other research initiatives. All episodes of care are
recorded and the reason for care classified under the
International Classification of Diseases (ICD) codes.
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(2) Midwives Perinatal Data Collection (MPDC)
The Queensland Health Statistics Unit collates the
MPDC data collected by clinicians at birth. This data
is collected separately from any administrative data
collection processes and is a legal requirement for all
‘birth attendants’ in Australia. All data collected are
items which are considered important for monitoring
perinatal health status and healthcare at state and
national levels. Data received from midwives is
entered into the MPDC with a range of mechanisms
to ensure data quality, including blinded double data
entry, to reduce data entry error. The MPDC form is
Figure 1 Far North Queensland. Source: (Wikipedia 2013).
Chamberlain et al. SpringerPlus 2013, 2:576 Page 5 of 13
http://www.springerplus.com/content/2/1/576
based on the National Health Data Dictionary
(Australian Institute of Health and Welfare 2012),
and although there have been variations between
Australian states and territories over time (Laws and
Sullivan 2004), validation studies in other states show
high sensitivity (>95%) for collecting GDM data
(Taylor et al. 2005; Metcalfe 2012).
(3) Laboratory data
Postpartum OGTT screening and diagnosis is
exclusively undertaken in the three local laboratories
(one public and two private) in far north Queensland.
Laboratories also conduct other glucose screening tests
(HbA1C, FPG, RPG), which can be provided by many
healthcare providers in the region. Private laboratories
are providing data on the type of T2DM screening test,
date of test, whether during pregnancy or not
(to exclude pregnancy screening), and test results.
The public laboratory data is being extracted onto a
database by clinical members of the research team who
are authorised to access patient information.
(4) CH Medical Record Review
Data from CHCC and MPDC is being linked on a
spread-sheet and downloaded into a Microsoft Access
database. A random sample of medical records of
women with GDM are being reviewed to ensure accur-
acy of case identification and confinement date,
complete missing electronic data fields, and collect
some additional data not available elsewhere (for ex-
ample, antenatal and postnatal care provider type, num-
ber of dietician and diabetic educator consultations,
indication for induction or caesarean section, provision
of artificial infant formula). The medical record review
is being conducted by a registered midwife. The first
10 medical records are being reviewed by both staff
together to ensure consistency of collection and 100
records co-reviewed to assess inter-rater reliability.
Data on postpartum screening from the Primary Health
Care Information System (PHCIS), used by many public
primary health care providers in far north Queensland,
has been examined but is not able to be extracted in a us-
able format for this study. Primary health care services
would not be able to provide OGTTs, which are the rec-
ommended screening and diagnostic test for T2DM
screening and the subject of this study. However there
may be some ‘point of care’ tests that will not be included
in this study, such as HbA1C, FPG, and RPG, which were
provided by primary health care providers. Postpartum
screening rates will be reported as proportions who re-
ceived the recommended screening tests (OGTT), or ‘Any
postpartum glucose screen’. The limitations about the
rates of ‘any’ postpartum glucose screens in the study will
be reported, with recommendations for future prospective
studies to collect these data.
Sample size calculation
A sample size of 325 Aboriginal and 325 non-Aboriginal
women has been calculated to be 80% powered to de-
tect a 10% difference in women receiving postpartum
screening for T2DM, with a 95% confidence interval.
These figures were based on consultation with experi-
enced clinical staff, who estimated that approximately
20% of Aboriginal women and 30% of non-Aboriginal
women currently receive postpartum T2DM screening.
Whether there is a significant difference will help to ascer-
tain whether some of the barriers or enablers to postpar-
tum care may be culturally-specific, or generic for all
women with GDM.
Study sample and case ascertainment
The study includes all women who gave birth at CH be-
tween 1/1/2004 to 31/12/2010 and have an appropriate
GDM ICD-10-AM code assigned (024.41, 024.42, 0.24.43,
0.24.44) in the CHCC and MPDC (Australian Institute of
Health and Welfare 2010b). Women with an ICD code in-
dicating pre-existing diabetes (024.0, 024.11, 024.12,
024.13, 024.14, 024.21, 024.22, 024.31, 024.32, 024.9) are
being excluded (see Table 1). The sample will include elec-
tronic records for 353 Aboriginal women and 659 non-
Aboriginal women, therefore the study will be adequately
powered to test the estimated 10% difference in postpar-
tum screening.
The quality of retrospective data in this study is being
improved by use of data linkage, and a review of a sample
medical records to ensure key variables are correct. The
sample selected for review includes medical records of all
Aboriginal (n = 353), all non-Aboriginal women living in
remote areas (n = 13), and a random sample of 236/659
(36%) non-Aboriginal women. The random sample has
been selected using a computer-generated random num-
ber sequence.
Outcome assessment
Primary outcomes for this study include the time to post-
partum OGTT or any laboratory-based glucose test, and
the proportions screened (OGTT or any) according to
recommended protocols:
 the proportion of women with GDM who received;
all postpartum OGTTs as per protocol
 times to screening test (OGTT or any)
 cumulative rates of OGTT or ‘any’ postpartum
glucose test at 6 weeks (0–6 months), 12 months
(6–24 months) and 3 years (24–48 months)
 the proportion of GDM pregnancies who received
an OGTT or any postpartum glucose test at 6 weeks
(0–6 months), 12 months (6–24 months) and
3 years (24–48 months), excluding tests providing in
the previous period.
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Women will be censored from ‘screening eligibility’
from:
 time of onset of subsequent pregnancies, calculated
as 273 days prior to subsequent pregnancy, or
20 weeks prior to date of test if test after 1/3/2010,
and coded as ‘during pregnancy’ (to capture possible
confinements after 31/12/2010).
 date of type 2 diabetes diagnosis, calculated if the
records from any datasource (e.g. medical records,
MPDC data, laboratory tests) indicated the women
developed type 2 diabetes. If a type 2 diabetes
diagnostic date is not available, the date of the glucose
screening test will be used as the censorship date.
All screening test results for each woman with GDM are
being assessed by a registered midwife on the research
team. The assessment includes (1) whether some or all of
the criteria for follow-up screening were met (see Table 2),
(2) whether further follow-up screening is recommended
(3) date of last screening test (4) date of diagnosis of
T2DM and test used for diagnosis, and (5) months from
date of confinement to screening. The records will be
reviewed by an expert diabetes clinician where it is unclear
whether further screening is recommended.
Secondary outcomes include:
(1)proportion of women with ‘probable’ T2DM
(diagnosis prior to 16 weeks gestation) who received
a postpartum OGTT;
(2)rates of follow-up screening for women identified as
having impaired glucose tolerance (OGTT annually);
(3)progression time from GDM to T2DM diagnosis;
(4)proportion of women with GDM for whom an
appointment with a dietician or diabetes educator
was recorded in the CHCC or medical records; and
(5)proportion of women with GDM for whom
breastfeeding at discharge and/or provision of
Table 2 Criteria used to assess adequacy of postpartum T2DM screening for women with GDM
1. Diagnosed with GDM in last pregnancy only (not any previous pregnancy) and:
● Is more than 6 weeks but less than 6 months postpartum and has not had a ‘6 week’ OGTT;
● Is more than 6 months postpartum but less than 2 years and has not had a ‘1 year’ OGTT;
● Is more than 2 years postpartum and previously identified ‘impaired glucose tolerance’ on any test
(OGTT, FPG, HBA1C or RPG), and has not had an OGTT in the past year.
● Is more than 3 years postpartum and has not had an OGTT in the last 2 years
● Had a FPG or RPG on any of the above occasions which was within the ‘impaired’ or ‘abnormal’ glucose tolerance range (as outlined in Table 3)
and did not have an OGTT.
2. Diagnosed with pre-existing T2DM in pregnancy and no record of any postpartum tests
Table 1 Diabetes in pregnancy International Classification of Disease (ICD) codes
ICD code Description Included in this study
O24.0 Pre-existing diabetes mellitus, Type 1, in pregnancy No
024.11 Pre-existing diabetes mellitus, Type 2, in pregnancy, non-insulin treated No
024.12 Pre-existing diabetes mellitus, Type 2, in pregnancy, insulin treated No
O24.13 Pre-existing diabetes mellitus, Type 2, in pregnancy, oral hypoglycaemic therapy No
O24.14 Pre-existing diabetes mellitus, Type 2, in pregnancy, other No
024.21 Pre-existing diabetes mellitus, other specified type, in pregnancy, non-insulin treated No
024.22 Pre-existing diabetes mellitus, other specified type, in pregnancy, insulin treated No
024.31 Pre-existing diabetes mellitus, unspecified, in pregnancy, non-insulin treated No
024.32 Pre-existing diabetes mellitus, unspecified, in pregnancy, insulin treated No
O24.41 Diabetes mellitus arising at or after 24 weeks gestation, non-insulin OR Diabetes
mellitus arising in pregnancy, non-insulin-requiring
Yes
O24.42 Diabetes mellitus arising at or after 24 weeks gestation, insulin treated OR
Diabetes mellitus arising during pregnancy, insulin treated OR Diabetes
mellitus arising in pregnancy, insulin-requiring
Yes
O24.43 Diabetes mellitus arising during pregnancy, oral hypoglycaemic therapy Yes
O24.44 Diabetes mellitus arising during pregnancy, other Yes
024.9 Diabetes mellitus in pregnancy, unspecified onset No
Source: Diabetes in pregnancy: its impact on Australian women and their babies (Australian Institute of Health and Welfare 2010b).
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artificial formula is reported in the MPDC data or
medical records. Analysis of secondary outcomes is
being conducted on the random sample validated by
medical record review (Table 3).
Assessment of rates of progression from GDM to
T2DM is being assessed by reporting the proportion of
women who have a positive diagnosis of T2DM recorded
in laboratory-based tests after GDM.
Confounding factors
A range of variables are being collected to examine a pos-
sible confounding effect on the primary outcomes, which
may identify barriers or enablers to postpartum screening
for T2DM. These include:
 Demographic factors: Aboriginal and Torres Strait
Islander status; Maternal country of birth; Requiring
a translator; Degree of remoteness of home address
based on the Accessibility/Remoteness Index of
Australia (ARIA) code.
 Clinical factors: Date of confinement; Pregnancy
outcomes; Parity; Previous diagnosis of GDM;
Gestational age of first antenatal visit and GDM
diagnosis; Treatment for diabetes in pregnancy;
Number of antenatal care visits; Body Mass Index;
Smoking in pregnancy; Medical or pregnancy
complications; Hospitalisations in pregnancy;
Induction; Mode of birth; Infant birth-weight; Infant
gestational age; Infant death.
 Service delivery factors: Antenatal and postnatal
care provider (Hospital, Private General Practitioner,
Government Health Clinic, Community Controlled
Health Service).
Indigenous status
Indigenous (Aboriginal) status is a measure of whether a
person identifies as being of Aboriginal or Torres Strait
Islander origin. Classification as Indigenous includes:
Aboriginal but not Torres Strait Islander origin; Torres
Strait Islander but not Aboriginal origin; or both Aboriginal
and Torres Strait Islander origin. People classified as non-
Indigenous (non-Aboriginal) are those not of Aboriginal or
Torres Strait Islander origin. Recent studies suggest there
is likely to be under-enumeration of Aboriginal status in
population-based datasets, by up to 40% (Population and
Public Health Division 2012), despite increases in the
number of people identifying as Aboriginal over time
(Australian Bureau of Statistics 2012).
See Additional file 1 for full list of data collected, data
source, and dictionary used for collection.
Data linkage
The security and protection of identifiable data have been
an absolute priority in this study. Collection and linkage of
identifiable data are being retained within secure infra-
structure, to ensure the privacy of individuals. Data for
women who gave birth at CH and were diagnosed with
GDM have been identified in the CHCC and exported into
a password protected file. This data includes the maternal
first name and surname, maternal date of birth, infant date
of birth, Medicare Number and GDM ICD code. This file
has been sent to the Queensland Health Statistics Unit to
securely provide relevant MPDC pregnancy and birth de-
tails, and to the private laboratories to provide T2DM glu-
cose screening and diagnostic data. Separate worksheets
have been developed for (1) Maternal details, with one rec-
ord for each mother, including GP details for follow-up, (2)
Pregnancy and birth details, with one record for each preg-
nancy, (3) Babies details, with one record for each baby,
and (4) Postpartum screening details, with one record per
screening test.
Data from CHCC and the MPDC are being combined
onto worksheets and downloaded into a Microsoft Ac-
cess© database for medical record review. Following me-
dical record review, postpartum glucose test data are being
assessed individually in relationship to each recorded preg-
nancy. If data suggests there is sub-optimal postpartum
T2DM screening and further T2DM screening is recom-
mended, letters are being sent to the woman’s primary care
Table 3 Normal glucose parameters
Test Glucose load Normal reference range Impaired glucose tolerance Abnormal glucose tolerance
Pregnant Not pregnant Pregnant Not pregnant Pregnant Not pregnant
OGTT Fasting/FPG 75 g 3.6–5.4 3.6–5.4 5.5–6.9 5.5–6.9 > = 7.0 > = 7.0
OGTT 1 h 75 g >10.0 >10.0
OGTT 2 h 75 g <5.5 <7.8 5.5–7.9 7.8–11.0 (Abnormal if FPG also >6.1) >8.0 >11.0
OGCT 1 h 50 g 3.6–7.7 na na >7.8
OGCT 1 h 75 g 3.6–7.9 na na >7.8
HBA1C NA <7% >7%
RPG NA <6.9 6.9–11.0 >11.00
Source: (American Association for Clinical Chemistry 2012; Colagiuri et al. 2009; Nankervis et al. 2013)
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provider, suggesting they offer the women a screening
test if their records also confirm T2DM screening has not
been undertaken.
Data analysis
De-identified data is being exported from Microsoft Ac-
cess© into Stata 11© for analysis. Preliminary descriptive
analysis will include assessment of the accuracy of GDM
case ascertainment during data linkage and medical record
review, with comparisons of rates reported in local Cairns
Diabetes Centre data and the National Diabetes Services
Scheme. General characteristics of mothers, pregnancies,
infant’s, and screening tests are being described. All ana-
lyses are being stratified by Aboriginal status. Multiple lo-
gistic regression analysis is being used to investigate
possible confounding and effect modification of variables
on the primary outcomes, including confinement year to
assess trends. Survival analyses and Kaplan Meir curves to
assess time from confinement coded as GDM until
OGTT or ‘any’ laboratory-based screening test, and
time for progression from GDM to T2DM. Univariate
hazards ratios will calculated using Cox proportional
hazards models to assess difference between Aboriginal
and non-Aboriginal women. Tests will be two tailed and
p < 0.05 will be considered statistically significant.
The time frames are the date of confinement (with GDM
pregnancy) to date of positive T2DM laboratory test result
to estimate the mean number of months. Where the diag-
nosis date is not available, the date of glucose screening test
which reports previous diagnosis of T2DM will be used.
Ethics
Ethics is a primary concern for any research involving
identifiable health information, particularly for Aboriginal
and Torres Strait Islander people. This research was con-
ducted in accordance with the Guidelines for Ethical
Conduct in Aboriginal and Torres Strait Islander Research
and the Public Health Act 2005. The research is in
partnership with the Aboriginal Community Controlled
Health Organisation (Apunipima Cape York Health
Council) and Aboriginal researchers are included on the
research team. The research was requested by clinical
service providers, thereby maximising the likelihood the
findings will be relevant and used for improving post-
partum care services for women diagnosed with GDM
in far north Queensland.
Ethical approval was granted for this project by the Cairns
Hospital and Hinterland Research Ethics Committee, the
Monash University Human Research and Ethics Committee
(no. 201101190), and approval for accessing data under the
Public Health Act granted by the Queensland Health
Research Ethics and Governance Unit. Further ‘site
specific applications’ were approved by the responsible
authority for each department and organisation involved
in collection of data, and the Queensland Health Re-
search Ethics and Governance Unit and Cairns Hospital
Research Governance Unit.
Discussion
This retrospective cohort study is using linked administra-
tive, registry and laboratory data, validated by medical re-
cord review, to evaluate the effectiveness of postpartum care
for women diagnosed with GDM in far north Queensland
from 2004 to 2010. This paper describes how existing data
can be linked to evaluate existing postpartum care and
examine potential barriers and enablers to postpartum care
for Aboriginal and non-Aboriginal women with GDM,
across different geographic localities. Furthermore, exa-
mination of case ascertainment accuracy will provide prac-
tical information on which data sources may be used to
assist postpartum follow-up.
A limitation posed by this retrospective analysis is that
low screening rates will underestimate the number of
women who progress from GDM to T2DM. While a pro-
spective cohort study would be a stronger study design for
the prosed research questions, the case for this must be
established by conducting the current study. The study
also uses administrative data for case identification, which
further underestimates the total number of women with
GDM. However we are using several strategies to assess
and improve data quality, such as data linkage and revie-
wing medical records. Another limitation is the inability to
include ‘point of care’ tests, such as HbA1C, RPGs, and
FPGs, therefore the ‘any test’ estimates in this study are
likely to be lower than the true glucose screening rates.
Nevertheless, OGTTs are recommended for postpartum
screening in the protocols we are evaluating, as both FPG
and HbA1C have lower sensitivity and will not detect iso-
lated impaired glucose tolerance (Keely 2012; Picon et al.
2012), and we believe our reporting of rates of postpartum
OGTTs in this region will be accurate.
The research is being conducted within a strong ethical
framework which includes Aboriginal people on the re-
search team, and is important to minimize the risk of
harm and ensure the current research is beneficial for par-
ticipants and the broader community. Service providers
have requested the research and are active members of the
research team, so it is highly likely the findings will be
used for improving health services.
Evaluation of postpartum T2DM screening has been
identified as a ‘high priority’ research need for GDM
(Bennett et al. 2012); particularly for Aboriginal women
who are at high risk for GDM and subsequent T2DM,
and are the subject of recent recommendations for in-
creased GDM screening in early pregnancy. These
changes to screening during pregnancy will be of little
benefit for Aboriginal women unless effective preven-
tion, treatment and postpartum care are provided. This
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research is urgently needed to improve postpartum care
for Aboriginal women with GDM, to mitigate the risks to
women, subsequent children, and future generations, and
to reduce health disparities experienced by Aboriginal
peoples.
Endnote
aThe term ‘Aboriginal’ is used when referring specifically
to Aboriginal and Torres Strait Islander people in Australia,
and the term ‘Indigenous’ is used when referring more
generally to Indigenous people’s worldwide. This is for
ease of reading in this paper only, and we respectfully
acknowledge the diversity and autonomy of Indigenous
peoples, including Torres Strait Islander people.
Additional file
Additional file 1: Data Dictionary.
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